方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| Cochrane偏倚风险工具2.0用于随机对照试验× | GRADE证据评估：评估证据确定性和推荐强度× | |
|---|---|---|
| 领域 | 研究方法论 | 研究方法论 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2019 | 2008 |
| 提出者≠ | Jonathan Sterne, Julian Higgins (Cochrane Collaboration) | Guyatt et al. (GRADE Working Group) |
| 类型≠ | Clinician-rated / Research team assessment | Research team / Guideline panel assessment |
| 开创性文献≠ | Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. DOI ↗ | Guyatt, G., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008). GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924–926. DOI ↗ |
| 别名 | RoB 2.0, RoB 2 | GRADE, GRADE approach |
| 相关 | 4 | 4 |
| 摘要≠ | RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias. | GRADE (Grading of Recommendations Assessment, Development and Evaluation) is a systematic, transparent framework for assessing the certainty of evidence and determining the strength of clinical recommendations in healthcare. Published in 2008 by Guyatt et al., GRADE has become the international standard for guideline development, used by the World Health Organization, Cochrane, and most major clinical guideline organizations worldwide. |
| ScholarGate数据集 ↗ |
|
|